quinuclidines has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appleyard, CB; Chen, Z; Coppola, D; Isidro, AA; Pagán, B; Ren, Y; Wu, J | 1 |
| Nakayama, Y; Shinohara, Y; Takahashi, K; Torigoe, T; Yamaguchi, K | 1 |
1 trial(s) available for quinuclidines and Colonic Neoplasms
| Article | Year |
|---|---|
[Evaluation of palonosetron for the prevention of nausea and vomiting induced by colon cancer chemotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting | 2012 |
1 other study(ies) available for quinuclidines and Colonic Neoplasms
| Article | Year |
|---|---|
Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Immunohistochemistry; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2010 |